|
SOX6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.112300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.440300E-02 |
| Normal-vs-Stage2 |
2.987000E-01 |
| Normal-vs-Stage3 |
4.582000E-01 |
| Normal-vs-Stage4 |
1.83722999999025E-05 |
| Stage1-vs-Stage2 |
9.328800E-01 |
| Stage1-vs-Stage3 |
8.061200E-01 |
| Stage1-vs-Stage4 |
1.022940E-03 |
| Stage2-vs-Stage3 |
9.080200E-01 |
| Stage2-vs-Stage4 |
1.775690E-02 |
| Stage3-vs-Stage4 |
2.666300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.137600E-02 |
| Normal-vs-AfricanAmerican |
5.728200E-01 |
| Normal-vs-Asian |
4.528000E-01 |
| Caucasian-vs-AfricanAmerican |
4.522600E-01 |
| Caucasian-vs-Asian |
8.812800E-01 |
| AfricanAmerican-vs-Asian |
7.228600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.757900E-03 |
| Normal-vs-Female |
7.533800E-01 |
| Male-vs-Female |
4.510200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.288000E-01 |
| Normal-vs-Extreme_Weight |
3.155700E-04 |
| Normal-vs-Obese |
2.181600E-01 |
| Normal-vs-Extreme_Obese |
2.215000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.309600E-01 |
| Normal_Weight-vs-Obese |
8.434800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.449600E-01 |
| Extreme_Weight-vs-Obese |
7.441900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.884200E-01 |
| Obese-vs-Extreme_Obese |
8.654800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.455200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.067800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.804700E-04 |
| Normal-vs-Age(81-100Yrs) |
2.819400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.194400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.818000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.003600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.888300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.733800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.181600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.024200E-03 |
| Normal-VS-Type2 PRCC |
5.594600E-01 |
| Normal-VS-KIRP CIMP |
4.23760000000106E-05 |
| Normal-VS-Unclassified PRCC |
4.122400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.659000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.581700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.512500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.882000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.641000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.400600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.662200E-01 |
| Normal-vs-N1 |
1.933400E-01 |
| Normal-vs-N2 |
1.449640E-02 |
| N0-vs-N1 |
6.148200E-01 |
| N0-vs-N2 |
7.716300E-02 |
| N1-vs-N2 |
3.134200E-01 |
|
|
